הרמונט
pfizer pfe pharmaceuticals israel ltd - ethinylestradiol; gestodene - טבליות מצופות - ethinylestradiol 0.020 mg; gestodene 0.075 mg - gestodene and estrogen - gestodene and estrogen - contraceptive.
מינס
pfizer pfe pharmaceuticals israel ltd - ethinylestradiol; gestodene - טבליות מצופות פילם - ethinylestradiol 0.015 mg; gestodene 0.06 mg - gestodene and estrogen - gestodene and estrogen - contraceptive.
אנדומטרין
ferring pharmaceuticals ltd - progesterone - טבליות וגינליות - progesterone 100 mg - progesterone - progesterone - progesterone supplementation or replacement in cases such as treatment of infertile women and ivf.
זומקטון 4 מג
ferring pharmaceuticals ltd - somatropin - אבקה וממס להכנת תמיסה להזרקה - somatropin 4 mg/vial - somatropin - somatropin - short stature due to pituitary growth hormone deficiency turner's syndrome children suffering from renal insufficiency. children : short stature due to inadequate or failed secretion of pituitary growth hormone or turner's syndrome. short stature in children with renal insufficiency.
זומקטון 10 מג
ferring pharmaceuticals ltd - somatropin - אבקה וממס להכנת תמיסה להזרקה - somatropin 10 mg - somatropin - somatropin - short stature due to pituitary growth hormone deficiency turner's syndrome, children suffering from renal insufficiency. children : short stature due to inadequate or failed secretion of pituitary growth hormone or turner's syndrome. short stature in children with renal insufficiency.
מינירין מלט 60 מקג
ferring pharmaceuticals ltd - desmopressin as acetate - טבליות מסיסות - desmopressin as acetate 60 mcg - desmopressin - desmopressin - nocturnal enuresis.
מינירין מלט 120 מקג
ferring pharmaceuticals ltd - desmopressin as acetate - טבליות מסיסות - desmopressin as acetate 120 mcg - desmopressin - desmopressin - nocturnal enuresis.
סומטולין אוטוג'ל 60 מג
medison pharma ltd - lanreotide as acetate - תמיסה להזרקה - lanreotide as acetate 60 mg/dose - lanreotide - lanreotide - somatuline autogel is indicated for the treatment of individuals with acromegaly when the circulating levels of growth hormone (gh) and/or insulin like growth factor-1 (igf-1) remain abnormal after surgery and/or radiotherapy, or in patients who otherwise require medical treatmfent .the goal of treatment in acromegaly is to reduce gh and igf-1 levels and where possible to normalize these values. somatuline autogel is also indicated for the treatment of symptoms associated with neuroendocrine (particularly carcinoid) tumors.
סומטולין אוטוג'ל 90 מג
medison pharma ltd - lanreotide as acetate - תמיסה להזרקה - lanreotide as acetate 90 mg/dose - lanreotide - lanreotide - somatuline autogel is indicated for the treatment of individuals with acromegaly when the circulating levels of growth hormone (gh) and/or insulin like growth factor-1 (igf-1) remain abnormal after surgery and/or radiotherapy, or in patients who otherwise require medical treatmfent .the goal of treatment in acromegaly is to reduce gh and igf-1 levels and where possible to normalize these values. somatuline autogel is also indicated for the treatment of symptoms associated with neuroendocrine (particularly carcinoid) tumors.
סומטולין אוטוג'ל 120 מג
medison pharma ltd - lanreotide as acetate - תמיסה להזרקה - lanreotide as acetate 120 mg/dose - lanreotide - lanreotide - somatuline autogel is indicated for the treatment of individuals with acromegaly when the circulating levels of growth hormone (gh) and/or insulin like growth factor-1 (igf-1) remain abnormal after surgery and/or radiotherapy, or in patients who otherwise require medical treatmfent .the goal of treatment in acromegaly is to reduce gh and igf-1 levels and where possible to normalize these values. somatuline autogel is also indicated for the treatment of symptoms associated with neuroendocrine (particularly carcinoid) tumors.